Moreover, the transwell invasion assay manifested that the sh-NR2F1-AS1 effect on HCC cells invasion was also partly restored by combining with miR-642a inhibitor (Figures 4(c) and 4(d)). The gene discussed is NR2F1; the disease is hepatocellular carcinoma.